Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods - Wikidata - awgldk - TriplyDB

Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods

Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods

http://www.wikidata.org/entity/Q35191584

about

Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance Antimicrobial Combinations against Pan-Resistant Acinetobacter baumannii Isolates with Different Resistance Mechanisms Activity of Fosfomycin- and Daptomycin-Containing Bone Cement on Selected Bacterial Species Being Associated with Orthopedic Infections.Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany.Diversity of Acinetobacter baumannii in four French military hospitals, as assessed by multiple locus variable number of tandem repeats analysis Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan Fosfomycin tromethamine. Antibiotic of choice in the female patient: A multicenter study.Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms.Fosfomycin Fosfomycin: Resurgence of an old companion.Fosfomycin, interesting alternative drug for treatment of urinary tract infections created by multiple drug resistant and extended spectrum β-lactamase producing strains.Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model.Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods.The Potential Role of Fosfomycin in Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.Inhibitory effects of vancomycin and fosfomycin on methicillin-resistant Staphylococcus aureus from antibiotic-impregnated articulating cement spacers.Blocking peptidoglycan recycling in Pseudomonas aeruginosa attenuates intrinsic resistance to fosfomycin.Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli.In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa.Carbapenem- and Colistin-Resistant Enterobacter cloacae from Delta, Colorado, in 2015.Detection of Multidrug Resistant (MDR) and Extremely Drug Resistant (XDR) P. Aeruginosa Isolated from Patients in Tehran, Iran.In vitro activity of fosfomycin against a collection of clinical Pseudomonas aeruginosa isolates from 16 Spanish hospitals: establishing the validity of standard broth microdilution as susceptibility testing method.Fosfomycin: Pharmacological, Clinical and Future Perspectives.Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model.

P2860

Q26853135-4EE31329-9EDD-49DB-A31B-1FEE04485F02 Q28550908-4176F3D0-02D4-4186-8E16-142E67AB1CB5 Q33581795-E454363F-3909-47C6-AFCF-626ED152F993 Q33703401-E349ED85-F190-4B1A-8A56-E0B74E5790FD Q34415986-061150DD-298B-4B4B-9283-B2AE1F87CC35 Q35025362-428970CE-6800-4F11-B148-8D0AC12DBAE5 Q35747796-C9A2F67C-42A8-47E7-8C5A-40CC20DF6357 Q36276787-A47A0BD7-2882-479C-80ED-CCC43C22DDBB Q36364199-1E5F8ED2-342D-49B6-A125-09DB0B9FE05C Q36675246-EAA5FE25-42BE-4AD7-8937-C762E19A4D42 Q36803694-B57CF521-4D15-4EBD-ABD0-70C975CA8D85 Q37001229-FE60BFAD-FEC9-4BBC-A8C8-A664EF62A7FD Q37287661-1D09DD9E-C65E-4FA5-961E-0F72493784DB Q38325217-EB2F44F1-A267-4A9C-B27F-50C0AEDDE58C Q38689344-F5549E11-2328-4E55-A54E-35B5E63E7B2C Q40309331-98736038-A476-4CCC-89AD-DDFDDE8EA62B Q40476281-EF425F02-3D72-4A55-BDDE-6147122A2AC3 Q40645840-51FFCA1E-4B17-4999-A81A-C9FF7924E68F Q40698278-151D146E-37B9-48D2-9CEB-C70B8D28BD9E Q40789035-DBB350FE-9702-4B1E-B03D-27281B1423CB Q41009249-17FBA6A5-080C-488D-91F3-ECCFED69F6E9 Q42930586-22923034-0E95-4099-BBD1-F616F752776B Q47136072-972EF2D3-18C9-43D2-8B4E-1B9EB6E66370 Q49667957-D41C18ED-F8CE-44F5-8DBB-BD2F4932B75C

P2860

Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods

http://www.wikidata.org/entity/Q35191584

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Antimicrobial susceptibilities ...... ion and disk diffusion methods

@ast

Antimicrobial susceptibilities ...... ion and disk diffusion methods

@en

type

label

Antimicrobial susceptibilities ...... ion and disk diffusion methods

@ast

Antimicrobial susceptibilities ...... ion and disk diffusion methods

@en

prefLabel

Antimicrobial susceptibilities ...... ion and disk diffusion methods

@ast

Antimicrobial susceptibilities ...... ion and disk diffusion methods

@en

P1433

Q35191584-A9474F76-79F9-4DF2-BAD3-EC03D99A348D

P1476

Q35191584-D0B045EF-8745-4FDA-8607-D58275DC59F1

P2093

Q35191584-438E19CF-22BF-45D2-BA2B-469D76D98D7A

Q35191584-6B3E4558-06F4-4220-A00A-EA154E65D89F

Q35191584-72392F35-9E83-4CAF-99D2-6C9F3C4A84CB

Q35191584-A1AA9174-B6A7-46D9-9524-9BF941D1BDC5

Q35191584-A5F4E6FB-558D-4475-9095-AA409CB88EA9

Q35191584-D4C87B8D-6F6F-4035-88E8-C0608E351753

P2860

Q35191584-1CF4CFA3-D26D-4BE8-96C7-4835F0D8E7B9

Q35191584-2C75E8F4-A8E5-40C2-906B-3766D11BF9C8

Q35191584-2FCF4AFB-FEE7-4CD3-B34D-490B265CE098

Q35191584-40027123-1A6F-4472-90CC-45AC17E78D3D

Q35191584-4FE71451-550E-46B4-B3BB-2C319511253B

Q35191584-6FC1DA2B-0480-4C41-A84F-71B7A63B086C

Q35191584-7A7917A6-66E6-4249-AAFF-E33251ED2ECC

Q35191584-8136FB01-AD36-4BE3-8104-FC1B56FDD129

Q35191584-8230424F-A295-4E38-A41B-F22D58B42373

Q35191584-8C2DF824-8907-464B-B43A-2BD796D62AEC

P304

Q35191584-9998BB72-DB16-488B-B8D7-1EF8C5A23092

P31

Q35191584-8217AEBC-38DB-4731-9E45-8A24A37EE3A4

P356

Q35191584-B552A1A5-BAB6-4AC6-8448-6BE20FD9432E

P407

Q35191584-0E99B722-7C17-4A9D-B980-9865BCDC0F06

P433

Q35191584-14582DE5-0E41-4A7D-83B8-6EAB55015B7F

P478

Q35191584-1C334677-DF59-4977-BF6C-BE9454050A23

P50

Q35191584-3772843E-81C1-4A93-969A-918D58B5F311

P577

Q35191584-59D561EF-3181-4578-9704-9967A8371093

P5875

Q35191584-4ABB0F96-D89F-471B-8C88-E7B49F343F62

P698

Q35191584-AC002153-94AA-41FA-8FCF-72BC22742CC9

P932

Q35191584-9D4344F4-E1C8-4AC5-91AD-B15A89A3C4FE

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Antimicrobial susceptibilities ...... ion and disk diffusion methods

@en

P2093

Chia-Ying Liu

http://www.w3.org/2001/XMLSchema#string

Ching-Lan Lu

http://www.w3.org/2001/XMLSchema#string

Chun-Hsing Liao

http://www.w3.org/2001/XMLSchema#string

John D Turnidge

http://www.w3.org/2001/XMLSchema#string

Lee-Jene Teng

http://www.w3.org/2001/XMLSchema#string

Yu-Tsung Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies.

Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies.

Susceptibility of urinary tract bacteria to fosfomycin

In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.

In vitro susceptibility testing procedures for fosfomycin tromethamine.

Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes

In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures.

Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.

Fosfomycin: use beyond urinary tract and gastrointestinal infections.

Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections.

P304

4295-4301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00349-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51216291

http://www.w3.org/2001/XMLSchema#string

P698

21670185

http://www.w3.org/2001/XMLSchema#string

P932

3165352

http://www.w3.org/2001/XMLSchema#string